Sarah L.Withey Preclinical Behavioral Biology Program, McLean Hospital, Belmont, Massachusetts, USA;Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USAMcLean Imaging Center, McLean Hospital, Belmont, Massachusetts, USA
Diego A.Pizzagalli Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USAMcLean Imaging Center, McLean Hospital, Belmont, Massachusetts, USACenter for Depression, Anxiety and Stress Research, McLean Hospital, Belmont, Massachusetts, USA
JackBergman Preclinical Behavioral Biology Program, McLean Hospital, Belmont, Massachusetts, USA;Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA
Abstract
Cite
Withey, Sarah L., et al. “Translational In Vivo Assays in Behavioral Biology”. Annual Review of Pharmacology and Toxicology, vol. 64, no. 1, 2024, pp. 435-53, https://doi.org/10.1146/annurev-pharmtox-051921-093711.
Withey, S. L., Pizzagalli, D. A., & Bergman, J. (2024). Translational In Vivo Assays in Behavioral Biology. Annual Review of Pharmacology and Toxicology, 64(1), 435-453. https://doi.org/10.1146/annurev-pharmtox-051921-093711
Withey, Sarah L., Diego A. Pizzagalli, and Jack Bergman. “Translational In Vivo Assays in Behavioral Biology”. Annual Review of Pharmacology and Toxicology 64, no. 1 (2024): 435-53. https://doi.org/10.1146/annurev-pharmtox-051921-093711.
Withey SL, Pizzagalli DA, Bergman J. Translational In Vivo Assays in Behavioral Biology. Annual Review of Pharmacology and Toxicology. 2024;64(1):435-53.